Surgepays Stock Performance
| SURG Stock | USD 1.39 0.02 1.42% |
The entity has a beta of 0.22, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Surgepays' returns are expected to increase less than the market. However, during the bear market, the loss of holding Surgepays is expected to be smaller as well. At this point, Surgepays has a negative expected return of -0.18%. Please make sure to validate Surgepays' treynor ratio, accumulation distribution, as well as the relationship between the Accumulation Distribution and price action indicator , to decide if Surgepays performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Surgepays has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders. ...more
| Begin Period Cash Flow | 7 M | |
| Free Cash Flow | 10 M |
Surgepays |
Surgepays Relative Risk vs. Return Landscape
If you would invest 165.00 in Surgepays on November 9, 2024 and sell it today you would lose (26.00) from holding Surgepays or give up 15.76% of portfolio value over 90 days. Surgepays is currently does not generate positive expected returns and assumes 4.8909% risk (volatility on return distribution) over the 90 days horizon. In different words, 43% of stocks are less volatile than Surgepays, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Surgepays Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Surgepays' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Surgepays, and traders can use it to determine the average amount a Surgepays' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0367
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SURG |
Estimated Market Risk
| 4.89 actual daily | 43 57% of assets are more volatile |
Expected Return
| -0.18 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Surgepays is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Surgepays by adding Surgepays to a well-diversified portfolio.
Surgepays Fundamentals Growth
Surgepays Stock prices reflect investors' perceptions of the future prospects and financial health of Surgepays, and Surgepays fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Surgepays Stock performance.
| Return On Equity | -0.0519 | ||||
| Return On Asset | -0.0151 | ||||
| Profit Margin | (0.01) % | ||||
| Operating Margin | (0.72) % | ||||
| Current Valuation | 9.19 M | ||||
| Shares Outstanding | 20.16 M | ||||
| Price To Earning | 11.14 X | ||||
| Price To Book | 0.86 X | ||||
| Price To Sales | 0.25 X | ||||
| Revenue | 137.14 M | ||||
| EBITDA | 20.08 M | ||||
| Cash And Equivalents | 8.7 M | ||||
| Cash Per Share | 0.70 X | ||||
| Total Debt | 5.44 M | ||||
| Debt To Equity | 6.32 % | ||||
| Book Value Per Share | 1.96 X | ||||
| Cash Flow From Operations | 10.29 M | ||||
| Earnings Per Share | (1.18) X | ||||
| Total Asset | 41.93 M | ||||
| Retained Earnings | (15.19 M) | ||||
| Current Asset | 46.28 M | ||||
| Current Liabilities | 9.69 M | ||||
About Surgepays Performance
By analyzing Surgepays' fundamental ratios, stakeholders can gain valuable insights into Surgepays' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Surgepays has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Surgepays has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
SurgePays, Inc., a financial technology and telecommunications company, provides services to the underbanked community in the United States. Further, it operates a bilingual operations center offering the Company with sales support, customer service, IT infrastructure design, graphic media, database programming, software development, revenue assurance, lead generation, and other various operational support services. Surgepays operates under SoftwareApplication classification in the United States and is traded on NASDAQ Exchange. It employs 32 people.Things to note about Surgepays performance evaluation
Checking the ongoing alerts about Surgepays for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Surgepays help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Surgepays generated a negative expected return over the last 90 days | |
| Surgepays may become a speculative penny stock | |
| Surgepays has high historical volatility and very poor performance | |
| About 32.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Surgepays' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Surgepays' stock is overvalued or undervalued compared to its peers.
- Examining Surgepays' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Surgepays' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Surgepays' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Surgepays' stock. These opinions can provide insight into Surgepays' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Surgepays Stock analysis
When running Surgepays' price analysis, check to measure Surgepays' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgepays is operating at the current time. Most of Surgepays' value examination focuses on studying past and present price action to predict the probability of Surgepays' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgepays' price. Additionally, you may evaluate how the addition of Surgepays to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |